About the pCPA
The pan-Canadian Pharmaceutical Alliance (pCPA) is a stand-alone not-for-profit organization. We lead and support negotiations with manufacturers on behalf of federal, provincial, and territorial drug plans to support sustainable public coverage and better health outcomes in Canada.
The pCPA is governed by a Board of Directors representing all member jurisdictions. Our unique, collective approach to negotiation leverages the combined negotiating power of participating public drug plans to achieve better prices for brand-name and generic drugs.
Land acknowledgement
The pCPA recognizes the inherent and treaty rights — as well as the history, strengths, and diversity — of First Nations, Inuit, and Métis Peoples, and we acknowledge the ancestral and unceded territories of Canada’s Indigenous Peoples. Our team is located across the country on several traditional territories, and we’re grateful to stand, live, and work on these lands.
We also acknowledge and recognize the many challenges and harms, past and present, experienced by First Nations, Inuit, and Métis communities when accessing, or trying to access, Canada’s healthcare system. The pCPA works toward improving health outcomes for all people in Canada.
This online impact report is also available as a PDF download.
Table of contents
Calibrating for what’s next: Growing the organization and our capabilities
Making headway: Highlighting meaningful progress through metrics and milestones
Exploring new routes: Expanding our expedited negotiation pathways
Handling the curves: Navigating uncertainty in the pharmaceutical ecosystem
Driving progress together: Collaborating and deepening relationships
Updating the roadmap: Developing a new strategic plan
Ready for the road ahead: Looking ahead
Governance: Members, leadership, Board of Directors, and financials